Comparative genomics using Candida albicans DNA microarrays reveals absence and divergence of virulence-associated genes in Candida dubliniensis.

Candida dubliniensis is a pathogenic yeast species closely related to Candida albicans. However, it is less frequently associated with human disease and displays reduced virulence in animal models of infection. Here comparative genomic hybridization was used in order to assess why C. dubliniensis is apparently less virulent than C. albicans. In these experiments the genomes of the two species were compared by co-hybridizing C. albicans microarrays with fluorescently labelled C. albicans and C. dubliniensis genomic DNA. C. dubliniensis genomic DNA was found to hybridize reproducibly to 95.6 % of C. albicans gene-specific sequences, indicating a significant degree of nucleotide sequence homology (> 60 %) in these sequences. The remaining 4.4 % of sequences (representing 247 genes) gave C. albicans/C. dubliniensis normalized fluorescent signal ratios that indicated significant sequence divergence (< 60 % homology) or absence in C. dubliniensis. Sequence divergence was identified in several genes (confirmed by Southern blot analysis and sequence analysis of PCR products) with putative virulence functions, including the gene encoding the hypha-specific human transglutaminase substrate Hwp1p. Poor hybridization of C. dubliniensis genomic DNA to the array sequences for the secreted aspartyl proteinase-encoding gene SAP5 also led to the finding that SAP5 was absent in C. dubliniensis and that this species possesses only one gene homologous to SAP4 and SAP6 of C. albicans. In addition, divergence and absence of sequences in several gene families was identified, including a family of HYR1-like GPI-anchored proteins, a family of genes homologous to a putative transcriptional activator (CTA2) and several ALS genes. This study has confirmed the close relatedness of C. albicans and C. dubliniensis and has identified a subset of unique C. albicans genes that may contribute to the increased prevalence and virulence of this species.

[1]  G. Moran,et al.  Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. , 2004, FEMS yeast research.

[2]  M. Pfaller,et al.  Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  J. Pronk,et al.  Comparative genotyping of the Saccharomyces cerevisiae laboratory strains S288C and CEN.PK113-7D using oligonucleotide microarrays. , 2003, FEMS yeast research.

[4]  D. Coleman,et al.  Differentiation of Candida dubliniensis from Candida albicans on Pal's Agar , 2003, Journal of Clinical Microbiology.

[5]  S. Challacombe,et al.  Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis , 2003, Microbiology and Molecular Biology Reviews.

[6]  S. Kelly,et al.  Investigation into the molecular mechanisms of itraconazole resistance in Candida dubliniensis , 2003 .

[7]  W. Gransden,et al.  Management and outcome of bloodstream infections due to Candida species in England and Wales. , 2003, The Journal of hospital infection.

[8]  J. Morschhäuser,et al.  The Candida dubliniensis CdCDR1 Gene Is Not Essential for Fluconazole Resistance , 2002, Antimicrobial Agents and Chemotherapy.

[9]  P. Sundstrom.  Adhesion in Candida spp , 2002, Cellular microbiology.

[10]  M. Schaller,et al.  Candida albicans Hyphal Formation and the Expression of the Efg1-Regulated Proteinases Sap4 to Sap6 Are Required for the Invasion of Parenchymal Organs , 2002, Infection and Immunity.

[11]  B. Wickes,et al.  Molecular Mechanisms of Fluconazole Resistance in Candida dubliniensis Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis , 2002, Antimicrobial Agents and Chemotherapy.

[12]  A. Colombo,et al.  Hypertonic sabouraud broth as a simple and powerful test for Candida dubliniensis screening. , 2002, Diagnostic microbiology and infectious disease.

[13]  D. Soll,et al.  Identification of Four Distinct Genotypes of Candida dubliniensis and Detection of Microevolution In Vitro and In Vivo , 2002, Journal of Clinical Microbiology.

[14]  M. Miyaji,et al.  Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans. , 2002, Medical mycology.

[15]  W. Merz,et al.  Recovery of Candida dubliniensis and Other Yeasts from Human Immunodeficiency Virus-Associated Periodontal Lesions , 2001, Journal of Clinical Microbiology.

[16]  J M Tiedje,et al.  DNA/DNA hybridization to microarrays reveals gene-specific differences between closely related microbial genomes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Staib,et al.  Isogenic Strain Construction and Gene Targeting inCandida dubliniensis , 2001, Journal of bacteriology.

[18]  A. Doney,et al.  Candida dubliniensis at a cancer center. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  L. Hoyer,et al.  The ALS gene family of Candida albicans. , 2001, Trends in microbiology.

[20]  J. C. Kapteyn,et al.  Characterization of agglutinin-like sequence genes from non-albicans Candida and phylogenetic analysis of the ALS family. , 2001, Genetics.

[21]  Jeremy D. Glasner,et al.  Genomic Interspecies Microarray Hybridization: Rapid Discovery of Three Thousand Genes in the Maize Endophyte,Klebsiella pneumoniae 342, by Microarray Hybridization with Escherichia coli K-12 Open Reading Frames , 2001, Applied and Environmental Microbiology.

[22]  D. Coleman,et al.  Differentiation of Candida dubliniensis fromCandida albicans on Staib Agar and Caffeic Acid-Ferric Citrate Agar , 2001, Journal of Clinical Microbiology.

[23]  Alexander D. Johnson,et al.  Identification and characterization of TUP1-regulated genes in Candida albicans. , 2000, Genetics.

[24]  H. Alakomi,et al.  Comparison of virulence factors of oral Candida dubliniensis and Candida albicans isolates in healthy people and patients with chronic candidosis. , 2000, Oral microbiology and immunology.

[25]  J. Meis,et al.  One-Year Prevalence of Candida dublinienis in a Dutch University Hospital , 2000, Journal of Clinical Microbiology.

[26]  D. Soll.  The Ins and Outs of DNA Fingerprinting the Infectious Fungi , 2000, Clinical Microbiology Reviews.

[27]  W. Coulter,et al.  Isolation of C. dubliniensis from insulin-using diabetes mellitus patients. , 2000, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[28]  S. Donnelly,et al.  Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. , 1999, Microbiology.

[29]  V. Phalip,et al.  Characterization of the biotin biosynthesis pathway in Saccharomyces cerevisiae and evidence for a cluster containing BIO5, a novel gene involved in vitamer uptake. , 1999, Gene.

[30]  H. Saluz,et al.  Identification of a gene encoding the pyruvate decarboxylase gene regulator CaPdc2p from Candida albicans , 1999, Yeast.

[31]  O. Kurzai,et al.  Rapid PCR Test for Discriminating betweenCandida albicans and Candida dubliniensisIsolates Using Primers Derived from the pH-Regulated PHR1and PHR2 Genes of C. albicans , 1999, Journal of Clinical Microbiology.

[32]  J. Staab,et al.  Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. , 1999, Science.

[33]  S. Donnelly,et al.  Identification and Expression of Multidrug Transporters Responsible for Fluconazole Resistance in Candida dubliniensis , 1998, Antimicrobial Agents and Chemotherapy.

[34]  D. Sullivan,et al.  Simple, Inexpensive, Reliable Method for Differentiation of Candida dubliniensis fromCandida albicans , 1998, Journal of Clinical Microbiology.

[35]  G. Gilfillan,et al.  Candida dubliniensis: phylogeny and putative virulence factors. , 1998, Microbiology.

[36]  N. Gow,et al.  A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence , 1997, Infection and immunity.

[37]  A. Johnson,et al.  Control of filament formation in Candida albicans by the transcriptional repressor TUP1. , 1997, Science.

[38]  G. Moran,et al.  Candidiasis: the emergence of a novel species, Candida dubliniensis , 1997, AIDS.

[39]  J. Becker,et al.  An oligopeptide transport gene from Candida albicans. , 1997, Microbiology.

[40]  A. Brown,et al.  The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins , 1996, Journal of bacteriology.

[41]  D. Coleman,et al.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. , 1995, Microbiology.

[42]  A. Brown,et al.  Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans , 1994, Molecular microbiology.

[43]  T. C. White,et al.  A fourth secreted aspartyl proteinase gene (SAP4) and a CARE2 repetitive element are located upstream of the SAP1 gene in Candida albicans , 1994, Journal of bacteriology.

[44]  S. Flint,et al.  Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation. , 1992, Journal of general microbiology.

[45]  D. Higgins,et al.  See Blockindiscussions, Blockinstats, Blockinand Blockinauthor Blockinprofiles Blockinfor Blockinthis Blockinpublication Clustal: Blockina Blockinpackage Blockinfor Blockinperforming Multiple Blockinsequence Blockinalignment Blockinon Blockina Minicomputer Article Blockin Blockinin Blockin , 2022 .

[46]  E. Southern.  Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.